Trial
NCT06983158
A Clinical Trial of CAP-002 Gene Therapy in Pediatric Patients With Syntaxin-Binding Protein 1 (STXBP1) Encephalopathy
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Capsida Biotherapeutics, Inc.
Collaborators
—
Condition
Developmental and Epileptic Encephalopathy
Intervention
gene therapy
Why stopped
Stopping rule for study was met
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-10